Year: 2022
T2759/17 – Closest prior art for assessing the inventive step of chemical inventions
Introduction
In decision T 2759/17 dated 7 October 2021, the Board of Appeal decided that, particularly in the field of …
Description Amendments at the EPO – the plot thickens
The story started on 1 March 2021 when the EPO updated their Guidelines for Examination to significantly tighten the requirement …
Plausibility: The need for data in pharmaceutical patent applications
In Sandoz Ltd v Teva Pharmaceutical Industries Ltd, the High Court found in its judgment that the use of …
A Unitary SPC? Will the Unitary Patent pave the way for a centralised SPC system?
Preparations for the Unified Patent Court (UPC) and European patent with Unitary effect (Unitary Patent (UP)) are nearing …
New requirements for sequence listings
On 1 July 2022, the new WIPO ST.26 sequence listing standard came into effect in all WIPO-contracting states. New PCT, …
Psychedelic drugs: recent breakthroughs and patent protection
Psychedelics are a class of psychoactive substances that cause changes in perception, mood, and cognitive processes. Examples include LSD, MDMA …
Patent term extensions (SPCs) for combination products
Often marketed medicines in Europe are authorised as a combination product containing a combination of active ingredients. In some instances, …
FemTech – the long-overlooked gap in the health market surrounding women’s health
Despite making up half of the planet’s population, women are significantly underrepresented in life sciences research. Until 1993, women were …
Nathan Chambers promoted to Associate
Nathan Chambers has been promoted to Associate after passing his exams to qualify as a Trade Mark Attorney.
Nathan joined …
